Respiratory Therapy and Devices
Breathing should never be a barrier to living life fully. Our respiratory solutions support patients by mobilizing secretions, easing the burden of chronic conditions and more. Treating conditions like cystic fibrosis, bronchiectasis and neuromuscular disorders, our therapies help patients breathe easily and live with confidence.

Explore Our Respiratory Therapy Products
Our products include cough assist and airway clearance systems, delivering advanced therapies like High-Frequency Chest Wall Oscillation (HFCWO) and Oscillation and Lung Expansion (OLE).
Find what you need on our digital catalog, including configurations, parts and accessories, ordering information, and more.
Why Choose Baxter
Respiratory Therapies Impact Outcomes
From pneumonia to chronic conditions, respiratory therapy has been shown to reduce hospital stays and lessen patient complications.
- 64% reduction in time on a ventilator1 when using oscillation and lung expansion (OLE) therapy
- 67% fewer acute exacerbations in bronchiectasis patients disease specific (P=.007)2 when using high-frequency chest wall oscillation (HFCWO)
- Two day reduction in patient days for neuromuscular patients (P<0.001)3 when using HFCWO
CARE Connex Program Provides Home Care Support
We’re supporting you and your patients throughout the therapy journey. Our dedicated team of 200+ experts provides:
- Guidance on insurance, warranty and financial options for your patients
- 24/7 clinical support and multilingual product assistance
- Professional device setup and configuration by licensed clinical trainers

Product Catalog
Looking for detailed information on products Baxter offers in the United States? Find what you need on our digital catalog, including configurations, parts and accessories, ordering information and more.

References
- Huynh TT, Liesching TN, Cereda M, Lei Y, Frazer MJ, Nahouraii MR, Diette GB, Efficacy of Oscillation and Lung Expansion in Reducing Postoperative Pulmonary Complication, Journal of the American College of Surgeons (2019).
- Basavaraj A, Choate R, Becker BC, Aksamit TR, Metersky ML; Bronchiectasis and NTM Research Registry Investigators. Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM research registry. Respir Med. 2024 Mar;223:107555. doi: 10.1016/j.rmed.2024.107555. Epub 2024 Feb 1. PMID: 38307319.
- Lechtzin N, Wolfe LF, Frick KD. The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases. Ann Am Thorac Soc. 2016 Jun;13(6):904-9. doi: 10.1513/AnnalsATS.201509-597OC. PMID: 26999271.
Disclaimers
For safe and proper use of product mentioned herein, please refer to the Instructions for Use or Operator Manual.
Baxter, CARE Connex, Monarch, Synclara, The Vest, Volara and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries. Any other trademarks, product names or brand images are the property of their respective owners.





